Dostarlimab Interactions
There are 588 drugs known to interact with dostarlimab, along with 3 disease interactions. Of the total drug interactions, 3 are major, and 585 are moderate.
- View all 588 medications that may interact with dostarlimab
- View dostarlimab disease interactions (3)
Most frequently checked interactions
View interaction reports for dostarlimab and the medicines listed below.
- Acidophilus Probiotic Blend (lactobacillus acidophilus)
- Adderall XR (amphetamine / dextroamphetamine)
- Adult Multivitamin Gummies (multivitamin with minerals)
- Advair HFA (fluticasone / salmeterol)
- Advil (ibuprofen)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Aleve (naproxen)
- Align (bifidobacterium infantis)
- Arexvy (rsv vaccine pref3, recombinant)
- Aspirin Low Strength (aspirin)
- Ativan (lorazepam)
- Bactrim DS (sulfamethoxazole / trimethoprim)
- Bonine (meclizine)
- Bystolic (nebivolol)
- Celebrex (celecoxib)
- Claritin (loratadine)
- Claritin-D (loratadine / pseudoephedrine)
- Clotrimazole Troche (clotrimazole)
- Colace (docusate)
- Compazine (prochlorperazine)
- Fish Oil (omega-3 polyunsaturated fatty acids)
- Flexeril (cyclobenzaprine)
- Gas-X (simethicone)
- Linzess (linaclotide)
- Norco (acetaminophen / hydrocodone)
- Pepcid (famotidine)
- Trulicity (dulaglutide)
- Tylenol (acetaminophen)
- Vitamin D3 (cholecalciferol)
- Zofran (ondansetron)
Dostarlimab disease interactions
There are 3 disease interactions with dostarlimab which include:
Report options
QR code containing a link to this page
More about dostarlimab
- dostarlimab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-PD-1 and PD-L1 monoclonal antibodies (immune checkpoint inhibitors)
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
